查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808843

非侵入性产前检测市场，依检测类型、技术、应用、最终用户、国家及地区划分－2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Non-invasive Prenatal Testing Market, By Test Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年非侵入性产前检测市场规模价值 72.1029 亿美元，2025 年至 2032 年的复合年增长率为 14.41%。

非侵入性产前检测 (NIPT) 是一种筛检技术，可透过检测孕妇血液中的胎儿 DNA 来识别唐氏症、爱德华兹氏症候群和帕陶氏症候群等染色体异常。它提供了一种比羊膜穿刺术和绒毛取样等侵入性方法更安全的替代方案，从而降低了母婴的风险。随着人们对遗传疾病认识的不断提高、测序技术的进步以及对早期准确胎儿健康评估的需求不断增长，NIPT 的应用也得到了推动。

产前护理基础设施的改善以及对个人化医疗日益增长的重视，进一步推动了市场的发展。越来越多的医护人员和准父母选择NIPT，因为它精准、便利且非侵入性。此外，NIPT与综合产前筛检计画的整合，也扩大了其临床应用范围。然而，伦理问题和监管框架持续影响市场趋势。全球高危险妊娠的增加也推动了需求，促使检测技术持续创新。

非侵入性产前检测市场-市场动态

对安全、早期和准确的胎儿基因筛检测试的需求不断增长。

准妈妈们对非侵入性、低风险产前检测的日益青睐，显着提升了对非侵入性产前检测 (NIPT) 的需求，从而推动了市场成长。根据美国妇产科医师学会 (ACOG) 的数据，传统的侵入性检测（例如羊膜穿刺术和绒毛取样）的流产风险约为 0.1-0.3%，而 NIPT 则透过简单的孕妇抽血，提供了更安全的替代方法。

NIPT 能够早期准确地检测出染色体异常，例如 21 三体综合征（唐氏症）、18 三体症（爱德华兹氏症候群）和 13 三体症（帕陶氏症候群），通常最早可在怀孕第 10 週发现。研究表明，NIPT 对唐氏症的检测敏感度和特异性均超过 99%，大大增强了检测结果的可信度。无细胞胎儿 DNA 分析技术的不断进步，提高了敏感度和特异性，使 NIPT 成为值得信赖的早期筛检方案。越来越多的医疗保健提供者推荐 NIPT 作为更安全的产前护理方案的一部分。

非侵入性产前检测市场－关键洞察

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 14.41%

根据测试类型细分，基于定序的 NIPT 预计将在 2024 年占据最大市场份额

根据技术细分，次世代定序 (NGS) 是 2024 年的领先技术

根据应用细分，唐氏症筛检是 2024 年领先的应用

按地区划分，北美是 2024 年的主要收入来源

非侵入性产前检测市场-細項分析：

全球无创产前检测市场根据检测类型、技术、应用、最终用户和地区进行细分。

根据检测类型，市场分为三类：基于定序的NIPT、基于微阵列的NIPT和基于PCR的NIPT。基于定序的NIPT因其高准确性和广泛的检测能力而占据主导地位。此方法利用新一代定序技术分析游离胎儿DNA，可同时检测多种染色体异常。与PCR或微阵列方法相比，基于终端使用者的定序方法灵敏度更高，甚至可以检测到母体血液中含量较低的胎儿DNA。

这种综合方法吸引了寻求可靠、多条件产前筛检的医疗保健提供者。定序通量的持续提升和成本的降低增强了其可及性和应用性。整合生物资讯学工具的能力进一步增强了临床解读。因此，基于定序的检测通常是常规NIPT的首选，这使得该领域成为市场领导者。

根据技术，市场可分为四大类：新一代定序 (NGS)、聚合酶炼式反应 (PCR)、微阵列和其他。在非侵入性产前检测 (NIPT) 市场中，按技术分類的最主要细分领域是新一代定序 (NGS)。 NGS 能够对母体血液中的胎儿 DNA 进行高度准确和全面的分析，彻底改变了产前筛检领域。它能够检测多种基因异常，包括常见的三体综合征（例如 21、18 和 13 三体综合征）、微缺失和性染色体非整倍体，这使其成为临床医生和诊断实验室的首选技术。

与传统方法不同，NGS 具有更高的灵敏度和特异性，减少了对羊膜穿刺等侵入性确认检测的需求。其可扩展性、通量和成本效益进一步提升了其应用，尤其是在拥有先进医疗基础设施的已开发国家。 Illumina、Roche 和 Natera 等大型诊断公司利用 NGS 平台提供 NIPT 解决方案，持续推动创新。

非侵入性产前检测市场—地理洞察

北美仍然是非侵入性产前检测 (NIPT) 的领先市场，这得益于其先进的医疗基础设施和早期采用的基因筛检技术。美国在该区域市场占据主导地位，这得益于产前健康意识的不断提升、大量需要筛检的孕妇以及完善的监管框架简化了产品审批流程。越来越多的医疗机构将 NIPT 纳入常规产前护理，这得益于医疗指南和宣传活动，这些活动旨在促进 NIPT 的普及。

美国也是NIPT的创新中心，拥有许多重要的产业参与者和研究机构。新一代定序和高效能实验室系统的日益普及显着缩短了检测週期，使检测更加便捷。随着产科医师不仅推荐高风险孕妇进行NIPT，也建议中度风险孕妇进行NIPT，NIPT的需求持续成长。

非侵入性产前检测市场-竞争格局：

非侵入性产前检测市场的竞争格局体现在快速的技术进步、强劲的研发投入以及主要参与者之间的策略合作。各公司正致力于扩展其检测范围，以涵盖更广泛的遗传疾病。定序终端用户和生物资讯学的创新提高了检测准确性，并缩短了周转时间，从而带来了竞争优势。

与医疗保健提供者和付款人的合作有助于提高市场渗透率和保险报销。一些参与者正在寻求向新兴市场扩张，以扩大客户群。竞争性定价和客製化的检测解决方案也发挥着重要作用。此外，法规合规性和资料隐私考量也是关键的竞争因素。合併、收购和合作进一步加剧了市场竞争。公司也投资于教育项目，以提高人们对NIPT益处的认识。

最新动态：

2025 年 5 月，Natera, Inc. 宣布推出新的扩展 NIPT 面板，针对更多罕见遗传疾病，以增强产前筛检能力。

2025年4月，Illumina公司推出了基于云端的定序平台软体升级，提高了NIPT资料分析的速度和准确性。

目录

第一章：非侵入性产前检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 非侵入性产前检测市场片段（依检测类型）
    • 非侵入性产前检测市场（依技术）
    • 非侵入性产前检测市场片段（按应用）
    • 非侵入性产前检测市场片段（按最终用户）
    • 各国无创产前检测市场概况
    • 非侵入性产前检测市场（按地区）
  • 竞争洞察

第三章：非侵入性产前检测主要市场趋势

  • 非侵入性产前检测市场驱动因素
    • 市场驱动因素的影响分析
  • 非侵入性产前检测市场限制
    • 市场限制的影响分析
  • 无创产前检测市场机会
  • 非侵入性产前检测市场未来趋势

第四章：非侵入性产前检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：非创产前检测市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：非侵入性产前检测市场格局

  • 2024年非侵入性产前检测市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：非侵入性产前检测市场－依检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 基于定序的NIPT
    • 基于微阵列的NIPT
    • 基于PCR的NIPT

第 8 章：非侵入性产前检测市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • 下一代定序（NGS）
    • 聚合酶炼式反应（PCR）
    • 微阵列
    • 其他的

第九章：非侵入性产前检测市场－按应用

  • 概述
    • 按应用细分市场占有率分析
    • 唐氏症筛检
    • 爱德华兹症候群筛检
    • 帕陶症候群筛检
    • 性染色体非整倍体筛检
    • 其他的

第 10 章：非侵入性产前检测市场 - 按最终用户

  • 概述
    • 按技术细分的市场份额分析
    • 医院和诊所
    • 诊断实验室
    • 研究机构

第 11 章：非侵入性产前检测市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美无创产前检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲无创产前检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区无创产前检测主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲无创产前检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲无创产前检测主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依测试类型）
    • MEA 市场规模及预测（依技术）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：主要供应商分析-非侵入性产前检测产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Illumina, Inc.
    • Roche Diagnostics
    • BGI Genomics
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • PerkinElmer, Inc.
    • Invitae Corporation
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • QIAGEN NV
    • Berry Genomics Co., Ltd.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
    • Fulgent Genetics
    • Genesis Genomics
    • GeneDx, Inc.
    • CooperGenomics
    • Congenica
    • GenePlanet
    • Integrated Genetics

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5492

Non-invasive Prenatal Testing Market size was valued at US$ 7,210.29 Million in 2024, expanding at a CAGR of 14.41% from 2025 to 2032.

Non-invasive prenatal testing (NIPT) is a screening technique that examines fetal DNA in a pregnant woman's bloodstream to identify chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It offers a safer alternative to invasive methods like amniocentesis and chorionic villus sampling, reducing risks for both mother and baby. The adoption of NIPT is being fueled by growing awareness of genetic conditions, advancements in sequencing technologies, and the rising demand for early and accurate fetal health assessments.

The market is further supported by improved prenatal care infrastructure and the growing emphasis on personalized medicine. Both healthcare professionals and expectant parents are increasingly choosing NIPT for its precision, ease, and non-invasive approach. Additionally, the integration of NIPT with comprehensive prenatal screening panels is expanding its clinical relevance. However, ethical concerns and regulatory frameworks continue to influence market trends. The global increase in high-risk pregnancies is also driving demand, prompting continued innovation in testing technologies.

Non-invasive Prenatal Testing Market- Market Dynamics

Rising demand for safe, early, and accurate fetal genetic screening tests.

The growing preference for non-invasive and low-risk prenatal testing among expectant mothers is significantly boosting the demand for Non-Invasive Prenatal Testing (NIPT), driving market growth. In contrast to traditional invasive procedures-such as amniocentesis and chorionic villus sampling-that carry a miscarriage risk of approximately 0.1-0.3% according to the American College of Obstetricians and Gynecologists (ACOG), NIPT offers a safe alternative through a simple maternal blood draw.

NIPT enables early and accurate detection of chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), often as early as the 10th week of pregnancy. Studies have shown that NIPT has a sensitivity and specificity of over 99% for detecting Down syndrome, greatly enhancing confidence in test outcomes. Ongoing advancements in cell-free fetal DNA analysis have improved both sensitivity and specificity, making NIPT a trusted option for early screening. Healthcare providers are increasingly recommending NIPT as part of safer prenatal care protocols.

Non-invasive Prenatal Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.41% over the forecast period (2025-2032)

Based on Test Type segmentation, sequencing-based NIPT was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) were the leading Technology in 2024

Based on Application segmentation, Down Syndrome Screening was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Non-invasive Prenatal Testing Market- Segmentation Analysis:

The Global Non-invasive Prenatal Testing Market is segmented on the basis of Test Type, Technology, Application, End-user, and Region.

The market is divided into three categories based on Test Type: Sequencing-based NIPT, Microarray-based NIPT, and PCR-based NIPT. The sequencing-based NIPT segment dominates due to its high accuracy and broad detection capabilities. This method analyzes cell-free fetal DNA with next-generation sequencing, allowing detection of multiple chromosomal abnormalities simultaneously. Sequencing End-user provides greater sensitivity compared to PCR or microarray methods, enabling detection of even low fetal DNA fractions in maternal blood.

This comprehensive approach appeals to healthcare providers seeking reliable, multi-condition prenatal screening. Continuous improvements in sequencing throughput and cost reduction enhance its accessibility and adoption. The ability to integrate bioinformatics tools further strengthens clinical interpretation. As a result, sequencing-based tests are often preferred for routine NIPT, making this segment the market leader.

The market is divided into four categories based on Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. The most dominant segment in the Non-Invasive Prenatal Testing (NIPT) market by technology is Next-Generation Sequencing (NGS). NGS has revolutionized the field of prenatal screening by enabling highly accurate and comprehensive analysis of fetal DNA from maternal blood. Its ability to detect a wide range of genetic abnormalities, including common trisomies (such as Trisomy 21, 18, and 13), microdeletions, and sex chromosome aneuploidies, has made it the preferred technology among clinicians and diagnostic laboratories.

Unlike traditional methods, NGS offers higher sensitivity and specificity, reducing the need for invasive confirmatory tests like amniocentesis. Its scalability, throughput, and cost-efficiency have further boosted its adoption, particularly in developed countries with advanced healthcare infrastructure. Major diagnostic companies like Illumina, Roche, and Natera leverage NGS platforms for their NIPT solutions, driving continuous innovation.

Non-invasive Prenatal Testing Market- Geographical Insights

North America remains a leading market for Non-Invasive Prenatal Testing (NIPT), supported by its advanced healthcare infrastructure and early adoption of genetic screening technologies. The United States dominates the regional landscape, driven by rising awareness of prenatal health, a large volume of pregnancies requiring screening, and well-defined regulatory frameworks that streamline product approvals. A growing number of healthcare providers now include NIPT in routine prenatal care, further supported by medical guidelines and awareness initiatives that promote testing adoption.

The U.S. is also a hub for innovation in NIPT, home to several major industry players and research institutions. The increasing use of next-generation sequencing and efficient laboratory systems has significantly reduced turnaround times, making the tests more accessible. Demand continues to rise as obstetricians recommend NIPT not only for high-risk but also for average-risk pregnancies.

Non-invasive Prenatal Testing Market- Competitive Landscape:

The competitive landscape of the Non-invasive Prenatal Testing Market is characterized by rapid technological advancements, strong R&D investment, and strategic collaborations among key players. Companies are focusing on expanding their testing panels to include a broader range of genetic conditions. Innovation in sequencing End-user and bioinformatics enhances test accuracy and reduces turnaround times, offering a competitive edge.

Collaborations with healthcare providers and payers help improve market penetration and insurance reimbursement. Some players are pursuing geographic expansion to emerging markets to increase their customer base. Competitive pricing and customization of testing solutions also play important roles. Additionally, regulatory compliance and data privacy considerations are critical competitive factors. Mergers, acquisitions, and partnerships further intensify market rivalry. Companies also invest in educational initiatives to raise awareness about NIPT benefits.

Recent Developments:

In May 2025, Natera, Inc. announced a new expanded NIPT panel targeting additional rare genetic conditions to enhance prenatal screening capabilities.

In April 2025, Illumina, Inc. launched a cloud-based software upgrade for its sequencing platform, improving NIPT data analysis speed and accuracy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Roche Diagnostics
  • BGI Genomics
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Invitae Corporation
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • QIAGEN N.V.
  • Berry Genomics Co., Ltd.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Fulgent Genetics
  • Genesis Genomics
  • GeneDx, Inc.
  • CooperGenomics
  • Congenica
  • GenePlanet
  • Integrated Genetics

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Sequencing-based NIPT
  • Microarray-based NIPT
  • PCR-based NIPT

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Down Syndrome Screening
  • Edwards Syndrome Screening
  • Patau Syndrome Screening
  • Sex Chromosome Aneuploidy Screening
  • Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Prenatal Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Prenatal Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Prenatal Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Prenatal Testing Market Snippet by Application
    • 2.1.4. Non-invasive Prenatal Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Prenatal Testing Market Snippet by Country
    • 2.1.6. Non-invasive Prenatal Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Prenatal Testing Key Market Trends

  • 3.1. Non-invasive Prenatal Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Prenatal Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Prenatal Testing Market Opportunities
  • 3.4. Non-invasive Prenatal Testing Market Future Trends

4. Non-invasive Prenatal Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Prenatal Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Prenatal Testing Market Landscape

  • 6.1. Non-invasive Prenatal Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Prenatal Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Sequencing-based NIPT
    • 7.1.3. Microarray-based NIPT
    • 7.1.4. PCR-based NIPT

8. Non-invasive Prenatal Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Others

9. Non-invasive Prenatal Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Down Syndrome Screening
    • 9.1.3. Edwards Syndrome Screening
    • 9.1.4. Patau Syndrome Screening
    • 9.1.5. Sex Chromosome Aneuploidy Screening
    • 9.1.6. Others

10. Non-invasive Prenatal Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes

11. Non-invasive Prenatal Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Prenatal Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Prenatal Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Prenatal Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Prenatal Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Prenatal Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Prenatal Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Roche Diagnostics
    • 12.2.3. BGI Genomics
    • 12.2.4. Myriad Genetics, Inc.
    • 12.2.5. Natera, Inc.
    • 12.2.6. PerkinElmer, Inc.
    • 12.2.7. Invitae Corporation
    • 12.2.8. Thermo Fisher Scientific, Inc.
    • 12.2.9. Laboratory Corporation of America Holdings (LabCorp)
    • 12.2.10. QIAGEN N.V.
    • 12.2.11. Berry Genomics Co., Ltd.
    • 12.2.12. Agilent Technologies, Inc.
    • 12.2.13. Eurofins Scientific
    • 12.2.14. Fulgent Genetics
    • 12.2.15. Genesis Genomics
    • 12.2.16. GeneDx, Inc.
    • 12.2.17. CooperGenomics
    • 12.2.18. Congenica
    • 12.2.19. GenePlanet
    • 12.2.20. Integrated Genetics

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us